Home » FDA Partially Grants Petition on Generic Opioid Testing

FDA Partially Grants Petition on Generic Opioid Testing

April 5, 2017

Pharmaceuticals Quality

The FDA partially granted a petition filed on behalf of Purdue Pharma concerning generic versions of an extended-release opioid.

To View This Article:

Login

15Feb
Successful Strategies for Digital Health in 2022: Who’s Doing Digital Well and How You Can Get Started
16Feb
Statistics and Data for Regulatory Professionals and Attorneys: Product Performance Evidence Made Easy
17Feb
Gene & Cell Therapy Regulation: Comparability and Other New Developments
23Feb
Supply Chain Solutions: How the Pharmaceutical Industry Can End In-Bound Issue
29Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
01May
MAGI's Clinical Research Hybrid Conference - 2022 East

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements